EVALUATION OF THE EFFICIENCY OF HEPATITIS B VACCINE PROPHYLAXIS IN CHILDREN IN THE REPUBLIC OF KARAKALPAKSTAN
Keywords:
To evaluate the intensity of specific post-vaccination immunity to Hepatitis B in young children in Nukus who completed the immunization course according to the 0–2–3–4 months schedule.Abstract
Specific vaccine prophylaxis is the main strategic tool recommended by the WHO to reduce the incidence of Hepatitis B virus (HBV) infection and prevent its severe outcomes, such as cirrhosis and hepatocellular carcinoma. The introduction of multicomponent combination vaccines into regional healthcare practices in the Republic of Karakalpakstan has optimized the National Immunization Schedule. This approach ensures high vaccination coverage among the pediatric population while minimizing the injection load. Monitoring post-vaccination immunity under the four-dose schedule is essential for evaluating regional epidemiological safety.
References
1.World Health Organization. (2017). Hepatitis B vaccines: WHO position paper – July 2017. Weekly Epidemiological Record, 92(27), 369–392.
2.Spearman, C. W., Afihene, M., Ally, R., Apica, B., Awuku, Y., Cunha, L., ... & Spearman, N. (2017). Hepatitis B in Africa: collaborative approaches to training and improving outcomes. The Lancet Gastroenterology & Hepatology, 2(12), 910–916.
3.Shakhmetova, L., Sadirova, S., & Karimova, M. (2021). Optimization of the National Immunization Schedule: Efficiency and safety of multicomponent combination vaccines in Central Asia. Central Asian Journal of Medicine, 8(3), 45–52.
4.Whitaker, J. A., Rouphael, N. G., & Safranek, J. P. (2022). Immunogenicity and long-term immunological memory of hexavalent and pentavalent hepatitis B-containing vaccines in infants. Vaccine, 40(15), 2234–2241.
5.Lavanchy, D. (2019). Worldwide epidemiology and control of hepatitis B. Clinics in Liver Disease, 23(3), 415–425.
6.Uzakov, K. K., & Atajanov, J. A. (2023). Epidemiological safety and seroconversion rates after hepatitis B vaccination among pediatric populations in the Aral Sea region. Uzbek Medical Journal, 11(2), 14–20.
7.Poorolajal, J., Hooshmand, E., Mahjub, H., Esmailnasab, N., & Jenabi, E. (2016). Long-term protection provided by hepatitis B vaccine and need for booster dose: A meta-analysis. Vaccine, 34(4), 423–431.